FGF10 and breast carcinoma: FGF10 stimulation of the breast cancer cell line MCF-7 [a cell line described as estrogen receptor-positive (ERpos)] drive the cells to a basal-like cancer phenotype with diminished dependency to estrogen associated with decreased sensitivity to treatments with anti-estrogen.